Vanderbilt Ingram Cancer Center Archive — Page 43 of 48
-
December 18, 2013
Targeting tumor “supply lines”
A metabolic enzyme plays a crucial role in vascular development and may be a good target for cancer therapies. -
December 5, 2013
Research climate must be enhanced: NCI director
The director of the National Cancer Institute, Harold Varmus, M.D., told an overflow crowd at this year’s Orrin Ingram Distinguished Lecture that he is concerned about the climate for discovery research in the United States. -
November 21, 2013
Therapeutic target for synovial sarcoma
Inhibitors of a signaling pathway that is critical to synovial sarcoma tumorigenesis may be useful treatments for this aggressive cancer. -
November 21, 2013
Photo: Cancer survivorship celebration
More than 650 cancer survivors, family members and cancer health care providers attended Vanderbilt-Ingram Cancer Center’s Cancer Survivorship Celebration earlier this month during a special evening dinner and concert at the Loveless Barn in Nashville. -
November 14, 2013
National Cancer Institute director set for Discovery Lecture
The director of the National Cancer Institute, Harold Varmus, M.D., will deliver the next Flexner Discovery Lecture on Thursday, Nov. 21. His lecture, “New Directions in Cancer Research,” will begin at 4 p.m. in 208 Light Hall. -
November 14, 2013
Family’s support enhances cancer research training
John F. Brock III, chairman and CEO of Coca-Cola Enterprises, his wife, Mary, and their three children have established an endowment to support an oncology fellowship at Vanderbilt-Ingram Cancer Center. The Brock Family Fellowship will provide financial assistance long into the future for young physicians, postdoctoral students and medical investigators who are furthering their training in cancer research. -
November 7, 2013
Breast SPORE lands NCI renewal
Vanderbilt-Ingram Cancer Center’s Breast Specialized Program of Research Excellence (SPORE) has been awarded a third round of funding from the National Cancer Institute (NCI).